Lipid Disorders
News
Overweight, obesity increase risk of cardiotoxicity from anthracyclines
Key clinical point: Being overweight or obese was significantly associated with a greater risk of developing cardiotoxicity among breast cancer...
News
Study shows faster increase in obesity prevalence among cancer survivors
Key clinical point: Cancer survivors had a significantly faster increase in obesity prevalence compared with adults without a history of cancer....
News
Metabolic health declining among the obese, despite improvements in BP and lipids
Key clinical point: Blood glucose and diabetes are on the rise among America’s obese. Major finding: Twenty-two percent of obese Americans now...
News
‘Clarion call’ to screen for, treat aldosteronism
Key clinical point: The Endocrine Society’s updated Clinical Practice Guideline for managing primary aldosteronism is “a clarion call” for...
Conference Coverage
GERD and sleep disorders often go hand in glove
DENVER – Nocturnal awakening, insomnia, and other sleep disorders are highly prevalent in individuals with GERD.
Commentary
What difference would an empagliflozin CVD indication make?
Conference Coverage
FDA panel narrowly endorses empagliflozin’s cardiovascular mortality benefit
In a 12-11 vote, a Food and Drug Administration advisory panel narrowly came down in favor of the agency adding a new labeling entry to the...
News
LEADER: Liraglutide lowers CVD risk in type 2 diabetes
Key clinical point: Liraglutide is associated with a decreased risk of cardiovascular events, compared with placebo, in patients with type 2...
Commentary
The end of polypill – statins for everyone
News
Pioglitazone safe and effective for steatohepatitis in T2DM
Key clinical point: Long-term pioglitazone is not only safe for patients with nonalcoholic steatohepatitis and prediabetes or type 2 diabetes, but...
News
Sweet spot found for LDL-C reduction to minimize risk
Key clinical point: A moderate target for LDL-C reduction achieves the greatest reduction in the risk of adverse events, compared with low or high...